BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
75 hedge funds and large institutions have $585M invested in Biohaven Pharmaceutical Holding Company Ltd. in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
46% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 13
9% more funds holding
Funds holding: 69 → 75 (+6)
Holders
75
Holding in Top 10
6
Calls
$1.05M
Puts
$258K
Top Buyers
| 1 | +$73.9M | |
| 2 | +$17.5M | |
| 3 | +$16M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$7.61M |
| 5 |
PA
Perceptive Advisors
New York
|
+$6.96M |
Top Sellers
| 1 | -$16.9M | |
| 2 | -$9.52M | |
| 3 | -$5.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.57M |
| 5 |
JPMorgan Chase & Co
New York
|
-$4.37M |